No Data
Why FedEx Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
Trending Stocks Today | Aptose Biosciences Surges 159.69% Post-Market
Xilio Therapeutics Shares Are Trading Higher After the Company Announced 7.85 Million of Its Shares Was Acquired by Gilead Sciences.
Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
Xilio Therapeutics to Present Initial Phase 2 Data for XTX101 at ASCO GI
Press Release: Xilio Therapeutics Appoints Caroline Hensley as Chief Legal Officer
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Jackson Frolic : Maybe next week? BioAge had a multi day rise after weaker news. The Gilead purchase was significant validation of the technology IMO